I. Introduction
The third component of complement, C3, plays an important role in the defense of mammalian organisms against microbial, fungal, viral, and parasitic infections. In addition, C3 and C3-derived peptides participate in inflammatory and immune regulatory reactions. The physiologic functions of C3 and of the complement system have been extensively reviewed [48, 67, 78, 82, 104] . This chapter deals exclusively with the molecular structure of the C3 gene and the control of its expression. There are several reasons to study these issues. First, the C3 gene provides a good model system in which to investigate eucaryotic gene expression. C3 is synthesized in a tissue-specific fashion, and its production is subject to regulation during acute inflammation. Second, inherited C3 deficiencies have been described in man and higher animals and, from studying the structure and expression of the normal and defective genes, the molecular basis of these deficiencies may be determined. Third, the biochemical properties of the C3 protein and its peptide derivatives and the physiologic effects of their interactions with other complement proteins, regulatory proteins, and cellular receptors must be understood in greater detail than is now possible. The analysis of C3 messenger RNA (mRNA), complementary DNA (cDNA), and the C3 gene will add to our comprehension of these properties.
One of the striking characteristics of the C3 protein is its capacity to interact specifically with a variety of other polypeptides: (a) It is the substrate for proteolytic cleavage at a single site by the C3 convertases of the classical and alternative pathways of complement activation. (b) It is one of the constituents of the classical and alternative C5 convertases and of the alternative pathway C3 convertase. (c) It interacts with the regulatory proteins I (C3b-inactivator) and H (/~IH) that participate in the first specific steps of the catabolism of C3. (d) It is a ligand for several C3 receptor proteins on the surfaces of different cell types (see chapters by R.D. Schreiber [89] and by D.T. Fearon [35] in this volume). (e) It is modified by glycosyl transferases, a signal-peptidase, and one or several as yet unidentified enzymes that cleave the precursor polypeptide, proC3, at specific sites to generate the mature c~ and/~ subunits of C3.
The main unresolved problem in the biochemical analysis of this protein is to determine the positions of the individual interactive sites with respect to its primary amino acid sequence and tertiary structure. The complete amino acid sequence of C3 is unknown, however, several groups of investigators are currently working on the sequence determination.
This chapter will begin with a description of selected properties of C3 mRNA and the producion and identification of C3 cDNA clones. A summary of information about functionally important domains of the polypeptide derived from cDNA sequences follows, and finally we review our current knowledge of the gene and its expression.
II. Structure of the C3 Gene
A. The Mouse C3 Gene 1) Properties of Mouse C3 mRNA. The liver is the principal site of C3 synthesis in mice, man, and other mammals. Extrahepatic synthesis occurs mainly in macrophages and monocytes and to a lesser extent in fibroblasts, gut epithelial cells, and a few other cell types of the lymphoid and the reticuloendothelial systems [21, 23, 24, 36, 94, 108, 109] . It has been reported that 1~ of total intracellular radiolabeled protein from primary tissue cultures of guinea pig liver cells is immunoprecipitable with anti-C3 sera. Also, 0.2~o of the total protein synthesized in a cell-free translation system primed with liver mRNA reacted with C3 antisera [16] . From these data it may be estimated that the abundance of C3 mRNA in rodent liver should be on the order of 0.2~o to 1~o. This estimation assumes an equal translation efficiency for all mRNA species and an efficient immunoreactivity of the translation products. The minimum size of C3 mRNA may be approximated from the length of the precursor polypeptide proC3. With a molecular weight of 170 000 for the intracellular guinea pig pro C3 [-16] and 175 000 for the cell-free translation product from mouse liver mRNA, a minimum size of 5 000 nucleotides was estimated for mouse C3 mRNA [75] . The length of mouse C3 mRNA has been determined in several ways by using cloned cDNA probes; the result is a size of 5 100 +_200 nucleotides, including a poly A tail with a mean length of 170 nucleotides [31] . C3 mRNAs from mouse macrophages and from rat livers were both shown to be of this size [74] . Based on the frequency of C3 clones in a cDNA library prepared from murine livers, the abundance of C3 mRNA is on the order of 0.2~o to 0.3~o, in accordance with the estimates derived above [31] . However, the relative abundance has not been measured precisely with quantitative RNA/DNA hybridization techniques and cloned probes.
2) Cloning and Sequence Analysis of Mouse C3 cDNA.
A library of mouse liver cDNA was prepared in the plasmid vector pBR322 and propagated in Escherichia coli by using standard technology. The resulting library represents mRNA species of the size class 5 000 nucleotides and longer. C3 cDNA clones were identified in this library by using hybrid promoted translation (hybrid selection of mRNA) [75] . The identity of C3 clones was confirmed by partial cDNA sequence analysis and comparison of the derived amino acid sequences with known protein sequence data from selected regions of rat, guinea pig, porcine, and human C3 [31] . The inserts carried by eight different cDNA clones represented partially overlapping sequences, beginning with the 3' end and extending over a continuous stretch of 4600 nucleotides of the C3 mRNA. The 5' end and the adjacent approximately 350 nucleotides of the mRNA were not represented in this library. These cDNA clones and the location of their insert sequences relative to the mRNA and the polypeptide chains are shown in Fig. 1 . Sequences corresponding to a region close to the 5' end of the mRNA are given in Fig. 2 . The sequence was later extended beyond the region cloned in primer extension experiments [31] . From a comparison of the derived amino acid sequence with the published sequences of the NH2-termini of the guinea-pig and human C3/~ subunits [42, 96, 98] , this region appears to encode the (Fig. 2) . Thus, the order of the subunits in the precursor polypeptide proC3 was deduced to be: NH2-//-c~-COOH, in agreement with the earlier conclusion of Goldberger et al. [42] . These investigators immunoprecipitated intracellular proC3 and extracellular mature C3 from radiolabeled tissue cultures and compared the NH2-termini of the precursor and of the mature subunits by radioamino acid sequencing to establish that the/~ subunit is located in the amino terminal portion of proC3. This conclusion was further supported by the identification of sequences encoding C3a (the anaphylatoxin peptide) and the C3e subunit at the expected positions in the central portion of the mRNA [31] . The cDNA sequences from the 5' terminal mRNA region further indicated that the initial translation product from C3 mRNA does not start with the NHz-terminal Ile-residue of the mature/~ subunit, but that it must contain an amino terminal extension peptide. From genomic DNA sequences, later results showed that the initial translation product must begin with a leader-or signal-peptide [-111] (see below and Fig. 6 ).
The amino acid sequences of the mouse C3a anaphylatoxin peptide and of adjacent regions in the precursor proC3 molecule are given in Fig. 3 . The COOHterminus of the mouse C3/3 chain has not been located precisely in this region because the amino acid sequence of mouse C3 is unknown. However, the COOH- " II  I  I  I  II  I  I   1  2  3  4  5  6  7  8 9 3' 5~..AUC CCC AUG UAU UCC AUC AUU ACU CCC AAU GUC CUA CGG CUG GAG AGC GAA GAG ACC AUC GUA CUG GAG GCC CAC GAU GCU CAG GGU GAC IPMYSIITPNVLRLESEETIVLGAHOAQGD AUC CCA GUC ACA GUC ACU GUG CAA GAC UUC CUA AAG AGG CAA GUG CUG ACC AGU GAG AAG ACA GUG UUG ACA GGA GCC AGU GGA CAU CUG AGA IPVTVTVQDFLKRqVLTSEKTVLTGASGHLR E AGC GUC UCC AUC AAG AUU CCA GCC AGU AAG ~A UUC AAC UCA GAU AAG GAG GGG CAC AAG UAC GUG ACA GUG GUG GCA AAC UUC GGG GAA ACG SVSIKIPASKEFNSDKEGHKYVTVVANFGET H GUG GUG GAG AAA GCA GUG AUG GUA AGC UUC CAG AGU GGG UAC CUC UUC AUC CAG ACA GAC CAG ACC AUC UAC ACC CCC GGC UCC ACU GUC UUA VVEKAVMVSFQSGYLFIQTDQTIYTPGSTVL UAU CGG AUC UUC ACU GUG GAC AAC AAC CUA CUG CCC GUG GGC AAG ACA GUC GUC AUC CUC AUU GAG ACC CCC GAU GGC AUU CCU GUC AAG AGA YRIFTVDNNLLPVGKTVVILIETPDGIPVKR GAC AUU CUG UCU UCC AAC AAC. CAA CAC GGC AUC UUG CCU UUG UCU UGG AAC AUU CCU GAA CUG GUC° AAC AUG GGG CAG UGG AAG AUC CGA GCC DILSSNNQHGILPLSWNIPELVNMGQWKIRA UUU UAC G~ CAU GCG CCG'AAG CAG AUC UUC UCC GCA GAG UUU GAG GUG AAG GAA UAC GUG CUG CCC AGU UUU GAG GUC CGG GUG GAG CCC AC, terminus of human C3 was established as Pro-Ala-Ala by Tack and colleagues [96] . A Pro-Ala-Ala tripeptide is also found in the mouse proC3 sequence derived from cDNA ( Fig. 3) . Assuming that this tripeptide is indeed the COOH-terminus of mouse C3# and that the NH2-terminal residues of mouse C3a are Ser-Val-Gln, the precursor molecule contains an additional four arginine residues between these regions that are not part of the mature protein. These residues must be removed during the process in which the precursor matures into the two-chain molecule. One can further deduce from the cDNA sequence that mouse C3a is a 78 amino acid residue peptide of the same length as rat C3a. In contrast, human and porcine C3a are 77 residues long [25, 47, 49] . The sequence shows that mouse C3a shares 72/78 residues (92~o homology) with rat C3a, and 52/77 and 50/77 residues with human and porcine C3a, respectively [25, 47, 49] . Furthermore, the cDNA sequence indicates that the cleavage of C3 by the C3 convertases occurs by hydrolysis of a single peptide bond. All of the amino acid residues contained in the C3c~-chain's cleavage site are retained either in the COOH-end of C3a or in the NH2-end of the C3e'-chain, confirming earlier reports [48, 96] .
The amino acid sequence of the thioester bond region [-95] was derived from the cDNA sequence (Fig. 4) . By comparison with published data on the protein sequence, this region is evidently highly conserved between mouse and human C3 (35/41 amino acid residues identical). In particular, all ten amino acid residues common to the thioester regions of human C3, C4, and ~2-macroglobulin, and which are considered essential for the functioning of this region [ 17, 45, 95, 99] , also occur in mouse C3. These residues are surrounded by a solid line in Fig. 4 . 
mouse GCC GGC UGU GGG GAA CAG AAC AUG AUU GGC AUG ACA CCA ACA GUC AUU GCG GUA CAC UAC CUG ~ ~, Fig. 4 Comparison of the amino acid sequences encompassing the internal thioester site from murine (predicted from the nucleotide sequence) and human [99] C3d. (Upper)., Portion of fragment 5 whose sequence was determined. (Lower) Numbering of amino acid residues in the C3d fragment is from Thomas et al. [99] . The boxes indicate conserved amino acid residues that are identical in human C3d, C4d, and c~2-macrogJobulin [17, 45] (Reproduced with permission, Ref. 31) the possibility that this is only an internal adenosine-rich stretch in the 3'-nontranslated region of the mRNA and that the real 3' end of the mRNA is located further downstream is not excluded. The COOH-end of the protein must be coded by this region or by sequences located further upstream. No amino acid sequences are known for mouse C3; therefore, only human C3e can be used for comparison. The COOH-terminal amino acids of the human C3e chain have been determined to be (Ala, Val)-Gly-Ser [96] . However, this tripeptide sequence has one uncertainty and neither matches nor resembles the mouse protein sequences derived from the cDNA sequence preceding the stop codons in any of the three reading frames. This could mean that murine and human C3 have very different COOH-termini. Alternatively, the sequence reported for the COOH-end of the human C3c~ chain may not correspond to the COOH-end of the initial translation product. The published tripeptide sequence could represent the COOH-end of a processed version of C3c~ generated from the initial translation product bY removal of carboxyterminal amino acid residues. Carboxyterminal processing of both the murine and human C4e-chains has recently been reported [-20, 50] and may also occur for C3.
3) Structure and Characterization of the Mouse C3
Gene. A gene library was constructed with liver DNA from adult mice of the inbred strain A/Jax by using the phage vector ~t1059. DNA was partially digested with the restriction endonuclease MboI, and DNA fragments of 13-23 kilo basepairs (kb) in length were recovered by preparative electrophoresis in agarose gels. The fragments were ligated into the Bam HI restriction sites of the phage vector, and phage particles were reconstituted by in vitro packaging with viral protein capsids. A library representing the entire Amouse genome was obtained and screened by plaque hybridization with radiolabeled, cloned C3 cDNA probes. Four genomic clones were isolated and characte-rized. Two of them, ~.MC3/KW4 (KW4) and 2Mc3/KW7 (KW7), contained one entire copy of the mouse C3 gene together with approximately 1.2 kb of Y-and 7 kb of 3'-flanking sequences [11 l] (Fig. 5 ). The gene is approximately 24 kb long, and the 5' and 3' ends were mapped precisely by comparative DNA sequence analysis of cDNA and genomic DNA. For this purpose, cDNA extending to the 5' end of the mRNA was generated in primer-extension experiments by using cloned cDNA fragments as primers [11 iI . In this manner, the sequence coding for the 5' end of the mRNA (cap) was located on the genomic DNA with a precision of + 2 nucleotides (position indicated by arrow in Fig. 6 ). A 232 bp Hind III-Bam HI genomic DNA fragment containing the cap site was sequenced, and the hexanucleotide TATAAA (termed a TATA-box, underlined in Fig. 6 ) was found 28 nucleotides upstream from the cap site. This hexanucleotide is a typical sequence in RNA polymerase II promoter regions of eucaryotic genes [26, 41] . The ATG translation initiation triplet is located 56 nucleotides downstream from the cap site. The following 72 bp contain coding information for a signal-or leader-peptide [13, 62] of typical amino acid sequence and composition [10] (Fig. 6 ). After the triplets coding for the 24 amino acids of the signal-peptide, the genomic DNA encodes the NH2-terminus of the mature C3fl chain (Ile-Pro-Met). The signal hypothesis states that secreted glycoproteins are synthesized as primary translation products containing a signalpeptide, most often located at their NH2-end. Signal peptides are generally removed co-translationally by specific proteolytic cleavage [13] . C3 is a secreted glycoprotein, and from the gene sequence, it appears that the primary translation product carries a signal peptide. glycine, and the transition dipeptide (Gly-Ile) is a preferred substrate for the signalpeptidases known so far, (d) it contains a proline within its last six residues, and (e) its central portion consists of eight hydrophobic residues in an uninterrupted sequence. One additional observation supports the hypothesis that the sequence described above is a signal-peptide. As evident from the genomic DNA sequence, it is coded by a separative first exon of the gene [111] (Fig. 6 ). The sequences coding for the signalpeptides of other genes (mouse immunoglobulin light chains, [102] histocompatibility antigens, [55, 56, 92] ) are often contained in a separate first exon of the gene. From these data, several general properties of the mouse C3 gene can be deduced. It is 24 kb long, four to five times longer than the mRNA coding sequences. Therefore, the ratio of noncoding to coding sequences is approximately 4:1. This number falls into the range found for other eucaryotic genes transcribed by RNA polymerase II. The gene must contain intervening sequences (introns) and sequences retrieved in the mature mRNA (exons), but their exact numbers, sizes, and locations have not yet been determined except for the first and second exons and introns [111] . The promotor region contains the principal sequence known to be conserved for many polymerase II genes, the TATA-box. The C3-TATA-box perfectly agrees with the consensus sequence in all six nucleotide positions [26, 41] . The distances from the TATA-box to the cap-site and from the cap-site to the translation initiation site fall into the usual range. Obviously, the promoter region will have to be studied in much greater detail to define other sequence elements relevant to the initiation of transcription by polymerase II and its regulation by tissue-specific and inflammatory signals.
With regard to expression control in general and to tissue-specific expression in particular, it is important to know the number of C3 genes present in one (haploid) set of mouse chromosomes. If the genome contains a family of several C3 genes, tissue-specific expression could be achieved through selective expression of one different member in each different producer tissue. Alternatively, if only one copy is present per haploid genome, then the same gene must be expressed in all the different producer tissues. If several gene copies are present in the genome, increased C3 synthesis during acute inflammation could be achieved through the "switching on" of additional, normally silent gene copies, whereas the rate of expression from the constitutively expressed gene could remain constant. Alternatively, if only one copy of the gene is present, then increased synthesis during inflammation most likely would require an increased rate of expression from this single gene. To investigate whether the mouse genome contains one or several variants of the C3 gene, mouse liver DNA was digested with restriction enzymes and subjected to Southern blot analysis in parallel with similarly digested DNA from a mixture of the recombinant phages KW4 and KW7 (Fig. 7) . A mixture of cloned cDNA fragments, including all of the C3 mRNA sequences obtained as cloned cDNA until now, plus the 232 bp genomic DNA fragment containing the 5' end of the gene were radiolabeled and used as probes. All of the Barn HI restriction fragments detected in the digest of genomic DNA also were found in one of the two phages (Fig. 7) . Similar results were obtained with the restriction enzymes ECoRI and Hind III (unpublished data). Therefore, the mouse genome carries only one type of C3 gene recognizable by this analysis. If more than one copy of the C3 gene was present, then all must give rise to the same Barn HI, ECoRI, and Hind III restriction patterns. This analysis did not exclude the possibility that several copies of the C3 gene exist per haploid set of chromosomes, however, if several copies do exist, they must all have strictly conserved patterns of restriction enzyme cleavage. In view of the known rapid evolution of intron sequences, this is considered improbable. To the authors' knowledge, no gene of comparable length (24 kb) with two or more copies per genome and with strictly conserved cleavage patterns for three different restriction enzymes has been reported in the literature. Therefore, precise titration of the gene copy number using quantitative Southern blot or liquid hybridization experiments is needed and must include calibration by internal standards. From the data available, the mouse genome contains only one copy of the C3 gene and no pseudogenes, and this is the copy represented by the two recombinant phages 2MC3/KW4 and 2MC3/KW7 [111] .
4) C3 Allotypes and Chromosomal Location of the C3
Gene. Electrophoretic variants of the mouse C3 protein were first discovered by Penalva da Silva and colleagues [77] using high voltage electrophoresis of fresh mouse serum in agarose gels. This technique had been used before [2, 4, 84] for the analysis of human C3 variants. Two murine variants were found, a fast migrating (F) protein and a slow one (S), similar to the two common forms found for human C3 [112] . Most inbred mouse strains were found to be homozygous for the S allele and only 4/46 strains had the alternative F allele. Penbred Swiss-Webster animals belonged to one of the three phenotypes S, F, or SF. The genes responsible for this variation were codominantly expressed and segregated as alleles of a single Mendelian locus. Segregation studies were performed after crossing S and F strains of known haplotypes in the major histocompatibility complex (MHC), and both the C3 and MHC markers were analyzed in the progeny. C3 and the MHC markers segregated together with a recombination frequence of 12%. The conclusion was that the C3 gene is linked to the MHC on mouse chromosome 17 but must be located outside the MHC, because the recombination distance between the MHC and C3 is 12 centimorgans (cM) whereas the MHC is less than 1.5 cM long. Natsuume-Sakai and coworkers [69] used different techniques (isoelectric focusing and immunofixation) and discovered two isoelectric variants of mouse C3. From the strain distribution of these variants and from breeding experiments, they concluded that the isoelectric variation of mouse C3 is inherited as an autosomal, codominant trait controlled by a single locus, designated C3-1. They observed linkage between C3-1 and the S region of the MHC and between C3-1 and the kidney catalase locus Ce-2 on chromosome 17. The distances reported were: C3-1/Ce-2=23cM; C3-1/S= 11 cM, in close agreement with the conclusion of Penalva da Silva et al. . The alleles controlling the isoelectric variants were called C3-1 a and C3-lb, but the relationship between these and the electrophoretic variants [77] was not established. Subsequently, the Japanese group raised a mouse alloantiserum directed against a determinant A carried by the product of the C3-la allele. With the help of this serum they detected a third allele, C3-1 c, at the C3-1 locus. The corresponding protein has a similar isoelectric point as the C3-1 a product but lacks the A determinant [70] . Later the same authors generated alloantisera capable of recognizing exclusively determinants B and C on the products of the C3-1 b and C3-1 ° alleles [71, 73] .
In subsequent studies the Japanese authors used both the isoelectric focusing technique and these alloantisera for phenotyping C3 variants. They performed a three-factor-cross analysis using "tufted" (tt), a mutant'gene locus 9 cM away from the centromere of chromosome 17. To determine definitely the chromosomal location of C3-1, they phenotyped backcross progeny for the expression of tf and C3-1, and established that a distance of 24 cM separated these two markers [-72] . Since the distance between tf and the MHC was known to be about 7 cM, the chromosomal arrangement was concluded to be: centromere-tf-MHC-C3. Rubinstein et al. [86] confirmed this arrangement, using glyoxalase (glo) instead of tf as a third marker in a three-factor-cross. Glo was located at 17 cM on the centromeric side of the MHC and C3-1 on the distal side at a distance of 11 cM.
The alloantisera were finally used to describe the molecular differences between the protein products of the three C3-1 alleles [-73] . After the three proteins were purified to homogeneity, they retained the same isoelectric and immunologic properties as in whole serum. Thus, the allotypic differences were attributed to differences in the primary structures of the corresponding gene products. By tryptic digestion, the allotypic determinants A and B were further located in the C3c fragment. All three proteins had very similar subunit sizes and compositions, distributions, and content of neutral sugars and sensitivity to tryptic digestion. The fi subunit of all three murine proteins were shorter than the human C3fl subunit by a molecular weight difference of 9 000. Whereas both the human c~ and B subunit are known to be glycosylated, only the murine C3a subunit was found to be glycosylated; the fl subunit was not, confirming earlier reports [37] . But, glycosylation differences alone could not account for the size difference between the murine and human fl subunit; therefore, a difference of the amino acid chain length is probably involved. In this context, it may be noted that Carroll and Capra [-19] have observed significant phylogenetic variation in the size of the C3fl subunit, but very little variation in the C3a subunit.
B. The Human C3 Gene 1) Preparation of Cloned Human C3 DNA Probes. The degree of relatedness between nucleotide sequences of mouse and human C3 was qualitatively evaluated in a Southern blot hybridization experiment (Fig. 8) . The patterns of restriction enzyme cleavage were identical for liver DNA from two inbred mouse strains, A/Jax (s/s) and GR if/0, homozygous for the two major electrophoretic variants S and F of the mouse C3 protein [-77] . In contrast, the cleavage patterns of human peripheral blood cell DNA generated with three restriction enzymes differed greatly in . This observation suggests the usefulness of mouse C3 c D N A as a probe to isolate h u m a n C3 genomic D N A clones. In this manner one h u m a n C3 genomic clone, 2HuC3 RI No. 5, was isolated from a gene library of partial EcoRI fragments of h u m a n D N A in a 2 replacement vector p r e p a r e d by Fritsch and eoworkers [39] . This clone contained a 12 kb EcoRI fragment of the h u m a n C3 gene and a flanking 5.2 kb fragment. The exon-intron m a p of the insert has not been determined, but from hybridization with mouse C3 c D N A probes representing different m R N A regions, this area contains coding sequences for part of the C3e subunit (Fey, unpublished results). To generate a specific probe for human C3 sequences, portions of the insert containing nonrepetitive sequences were subcloned. For this purpose purified 12 kb and 5.2 kb insert fragments were digested with several restriction enzymes, and the fragments were analyzed by Southern blot analysis with total nick-translated DNA from human peripheral blood cells used as a probe. Insert fragments giving rise to a hybridization signal under these conditions contain repetitive sequences. In this experiment, a 1.39 kb Pst I subfragment of the 12 kb insert fragment was found to be nonrepetitive and it was subcloned [110] back to e-chain coding sequences of mouse C3 cDNA, they must, at least in part, represent exon sequences of the human C3 gene. From this experiment it was also evident that almost all subfragments of the 2Hu C3 RI No. 5 insert that are larger than 2 kb contain highly repetitive sequence elements. This is in agreement with the generally accepted model that human intron sequences are interspersed with short stretches of highly repetitive sequence elements (200-300 bp long) in an average distance of not more than 2 kb [29] . For this reason, the genomic clone 2HuC3 RI No. 5 could not be used directly for chromosomal mapping studies. The clones px HuC3 pst 1.39 and M13 HuC3 pst 1.39 are at present the best unique sequence probes available for the human C3 gene. When DNA preparations from nucleated peripheral blood cells and tissue culture fibroblasts from nine unrelated human donors were tested by Southern blot analysis, the 12 kb ECoRI fragment was found in all these samples by usiflg the pst 1.39 kb probe [110] . The 12 kb fragment showed no polymorphism, although the donors originated from different countries (Germany and England), and can therefore be considered a diagnostic fragment for the human C3 gene.
2) Polymorphic Variants of the C3 Gene. Two electrophoretic variants of the C3
protein, a slow and a fast migrating form, show inheritance patterns defining them as the products of two common allelic versions (C3 S and C3 F) of the gene [2, 4, 84, 112] . In Caucasian populations these genes occur with frequencies of 0.79 and 0.20, respectively, whereas in Blacks C3 F is much less frequent and in at least one Oriental population group published, no polymorphism was detected [3] . In addition, until now 26 rare protein variants have been detected by one-dimensional electrophoresis and recognized in family studies as allelic gene products (Rittner, personal communication) and four rare variants by using two-dimensional electrophoresis (Teisberg and Olaisen, personal communication). Together the rare variants occur with a frequency of 0.01 in Caucasian populations. The twodimensional electrophoresis showed that the two common and the four rare variants studied so far all had charge differences in the fi chain in accordance with the findings of Carroll and Capra [19] . The molecular basis of the differences in electrophoretic mobility of these protein variants is unexplained. More variants of the gene will probably be discovered on the DNA level, because even gene variants that differ only in intron sequences but code for identical proteins can be detected. Initial data are available from three independent laboratories (Davies and colleagues, London; Roper and colleagues, Freiburg; Roses and colleagues, Durham, personal communication) demonstrating restriction enzyme fragment length polymorphisms (RFLP's) of the C3 gene that are detectable by hybridization with the pxHu C3 pst 1.39 probe. In family studies these gene variants were shown to segregate as alleles of the gene.
3) Chromosomal Location of the Human C3 Gene. The human C3 locus has been assigned to chromosome 19 [110] . Somatic cell hybrids, between human primary fibroblasts and mouse fibroblast-like cell lines, which carried a limited number of different human chromosomes were analyzed for the presence of the C3 gene. Two approaches were used: production of human C3 in particular hybrid cultures was detected using a monoclonal antibody with specificity for the human but not the mouse gene product; and DNA samples from particular hybrid cultures were analyzed in Southern blot hybridization experiments using the DNA probe pxHu C3 pst 1.39 to detect the presence of the characteristic human C3 12 kb EcoRI fragment. Evidence of the presence of the human C3 gene was correlated with the known human chromosome content of the somatic cell hybrids. In the first approach, presence or absence of the human gene product correlated exclusively with the presence or absence of human chromosome 19 in 23 different somatic cell hybrids (Table 1 ) and in the second approach a similar exclusive correlation of the 12 kb EcoRI fragment with chromosome 19 was observed in eight different hybrids ( Table 2) .
The assignment of the C3 gene to chromosome 19 has allowed the assignment of an extensive linkage group to this chromosome. Linkage between C3 protein polymorphisms [3, 4, 112] and a linkage group comprising the previously linked Lewis blood group (LE), myotonic dystrophy (DM), ABH secretor system, and the Lutheran blood group (LU) loci 1-44, 63, 83] was established [32] . This extended linkage study confirmed the previous findings of linkage between C3 and LE [105] , and between C3 and DM [91] . The entire C3-LE-DM-SE-LU linkage group has subsequently been shown to be linked with the peptidase D locus (PEPD) [33] which had previously and independently been assigned to chromosome 19 [59] .
From the Southern blot hybridization experiments using pxHu C3 pst 1.39 it was concluded that the human haploid genome probably contains only one copy of the C3 gene. The pst 1.39 probe detected only one ECoRI restriction fragment, the 12 kb fragment, in Southern blot experiments with human DNA. If the genome carried several copies of the C3 gene or closely related genes, then all of these should be located on chromosome 19 and all should give rise to an indistinguishable 12 kb ECoRI fragment. Multiple loci are not formally excluded by these results but were considered very improbable for the reasons discussed above with the mouse C3 gene. Southern blot experiments with DNA from peripheral blood cells and sperm cells from the same human donor further revealed no major detectable rearrangement of the gene between its germ line and somatic cell configuration (Fig. 9) . The C3 gene, as far as can be detected with the presently available probes, is therefore different from immunoglobulin genes.
Most recently the chromosomal assignment has been further confirmed. Restriction fragment length polymorphisms (RFLPs) of the human C3 gene have been discovered in English, German, and American populations by Southern blot [110] analysis using the pxHu C3 pst 1.39 probe. RFLPs were detected for the enzymes Sst I, Taq 0  20  3  2  1  2  5  3  21  4  0  0  4  4  4  22  1  2  3  2  3  5  23  4  0  0  4  4  4 + +, Probe hybridizes (chromosome present); -, probe does not hybridize (chromosome not present); + -, probe hybridizes (chromosome not present); -+, probe does not hybridize (chromosome present). Data are summarized from karyotype and/or enzyme marker analysis of eight human-mouse somatic cell hybrid subclones [110] 4) A Family Presenting Inherited Human C3 Deficiency. Inherited partial and total C3 deficiencies in man and higher animals have been described but they are rare [6, 113, 114] . The field has been carefully reviewed [3, 5] ; therefore we restrict ourselves here to a few selected observations. The standard concentration of C3 in human serum ranges from 1 to 2 mg/ml. In comparison, heterozygous deficient individuals have serum levels reduced to half normal values. If one admits the single locus model of the C3 gene, these observations can be explained by postulating one completely inactive allele (null allele) and one co-dominantly expressed normal allele [69, 77-1. Partial deficiencies would imply a partially inactive gene product or partially reduced synthesis of a normal product from at least one defective allele. Carriers of partial deficiency are generally healthy. Only minor defects in complementmediated functions can be detected in their serum. The residual C3 concentration is apparently sufficient to maintain the essential defense and immune regulatory functions of C3.
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• -12 kb Fig. 9 . The human C3 gene is not somatically rearranged. DNA was prepared from sperm cells and peripheral blood cells of the same human donor, and digested separately with one of the four different restriction endonucleases: PstI, HindIII, BamHI, and EcoRI. The fragments were separated by electrophosesis in an agarose gel and subsequently transferred to a nitrocellulose filter (Southern blot). The filter was hybridized with nicktranslated plasmid DNA from plasmid pxHuC3 Pst 1.39 carrying a nonrepetitive sequence (probably exon-DNA) of the human C3 gene [110] . Size markers were contained in the same gel, and the position of the diagnostic 12 kb EcoRI fragment of the human C3 gene is indicated. Tracks 1 to 4: sperm DNA digested with PstI, HindIII, BamHI, and EcoRI. Tracks 5 to 8: blood cell DNA digested with the same enzymes Total (homozygous) C3 deficiency in man is very rare. Only approximately half a dozen families of this kind have been reported [6, 8, 9, 11, 28, 43, 46, 76, 81, 85] . In affected individuals, the complete absence of C3 is usually associated with such recurrent, pyogenic infections as pneumonia, septicemia, otitis media, and meningitis [-8, 9, 11, 28, 43, 46, 76, 81, 85] . Several individuals with a total C3 deficiency have died as children from severe infections. Replacement of functional C3 by transfusion of normal plasma into deficient patients transiently eliminates the symptoms of these systemic infections [-76] . Sera from several homozygous C3 deficient subjects studied in vitro showed a significant reduction or absence of most complement-mediated functions such as hemolytic activity for antibody-sensitized sheep red blood cells, opsonization of endotoxin particles, and chemotactic and bactericidal activities [-8, 9, 85] . Reconstitution of the deficient sera with purified normal C3 compensated for these defects.
The most recently published study describes a Dutch family [85] whose pedigree is reproduced in Fig. 10 , with the kind permission of Dr. John Roord and colleagues, University Hospitals, Utrecht and Leiden, The Netherlands. Both parents are considered heterozygous deficient by virtue of the reduced C3 concentrations in their sera and the inheritance pattern of this deficiency in their offspring. The parents are related in the seventh degree. They never exhibited serious illness and are free from clinical symptoms. Two of their 13 children died, one at the age of three years from bacterial meningitis and the other at the age of six years in a car accident. This child had no history of recurrent infections. However, three of the remaining children have recurring severe infections; one suffers from severaly impaired motor and mental development that began after the first of three episodes of meningitis. Other than this impairment a long-term regimen of ampicillin prophylaxis kept these patients well, until an attempt to discontinue the antibiotics resulted in renewed infections in two of the patients that necessitated resumption of continuous antibiotic prophylaxis. These three patients have no immunochemically detectable C3 antigen in their sera and only 1-2~ of normal C3 hemolytic functional activity. Six of the other children are presumably heterozygous deficient; another two are normal. These eight are free from symptoms and have no history of recurrent infection.
Until now, none of the inherited defects leading to partial or total C3 deficiency have been mapped to the structural locus coding for the C3 protein. Also, there are no well-documented reports of C3 protein mutants, although one recent publication contains circumstantial evidence for a structural mutation of the C3 protein [57] .
To further define the molecular nature of defects leading to inherited C3 deficiencies, the first necessity is to map the site of mutation. Then one must distinguish between second-site mutations (affecting a control locus involved in the expression of the C3 gene or the biosynthesis of the C3 protein) and structural mutations in the coding sequences for the C3 protein. On the DNA level, such major alterations of the structural gene as deletions, insertions, or rearrangements are generally detectable by comparative Southern blot analysis with DNA from deficient and normal individuals. These studies have been difficult to perform in the past due to the limited amounts of DNA available from the patients. To generate an unlimited supply of DNA from members of the Dutch family, peripheral blood Blymphocytes from seven family members were transformed with EPStein-Barr Virus (Drs. Yvonne Boyd, D. Hunter, and J. Edwards, unpublished data; personal communication). Cell-lines were established in culture from one of the parents, all three homozygous deficient children, two that were heterozygous, and one normal child. These cell lines will be used for the analysis of the defect at the DNA level.
III. Expression of the C3 Gene

A. Tissue Specific Expression
The C3 gene is subject to several levels of control. Most obvious is the restriction of its expression to production to only a few tissues. In addition, hormones and also inflammatory signals control the quantities of C3 circulating in the bloodstream and, therefore, probably the rates of synthesis in the producer tissues.
The bulk of the circulating serum C3 is synthesized in the liver. Alper and colleagues convincingly demonstrated this point by assaying plasma proteins following orthotopic liver transplantation [7] . By taking advantage of the structural polymorphisms of C3, C6, C8, and factor B, they showed that more than 90~ of the circulating forms of these proteins are synthesized in the liver. In addition, synthesis of C3 was demonstrated in primary hepatocyte cultures and in hepatoma cell lines [23, 36, 52, 64, 65, 93] (Fig. 11, tracks 3 and 4) . These data strongly suggest that the hepatocytes are the major site of synthesis of C3. The percentage of hepatocytes involved in C3 synthesis under normal and inflammatory conditions is unknown.
C3 is also synthesized outside of the liver. Fragments of synovial tissues obtained from patients with rheumatoid arthritis were capable of synthesizing functional C3 as well as C4 and factor B, whereas similar tissues from patients with degenerative or traumatic joint diseases failed to synthesize C3 in detectable amounts [87] . Other secondary sites of C3 synthesis include macrophages [21, 22, 37] monocytes [34, 108] , spleen cells, lymphoid cells, and other tissues of the reticuloendothelial systems as well as a few epithelial cell types [90, 101] and fibroblasts in tissue cultures [90, 109] . Gut-associated cells (hepatocytes and epithelial cells of the genitourinary and intestinal tracts) and cells of the reticuloendothelial system (macrophage/monocyte series) are the principal producers not only of C3 but also of most of the other complement proteins [23, 36] .
Preliminary evidence has been presented to demonstrate the synthesis, but not the secretion, of several complement components by peripheral blood lymphocytes [94] . Peripheral blood monocytes synthesize and secrete C2, C3, C4, C5 factors B, D, P, I, and H as antigenically recognizable products and functionally active C2, B, P, D, and I. However, these cells do not secrete functionally active C3, C4, C5, C6, C7, or C9 in conventional tissue cultures [34, 108] .
The molecular differences in C3 protein synthesized by monocytes that render this product funtionally inactive compared to C3 from hepatocytes are unknown. The quality in question may be a different pathway of C3 biosynthesis in these two tissues. Circumstantial evidence supporting this idea has been provided by a report . Cells were metabolically labeled by adding 50--120 gCi of 35S methionine (103 Ci/mmol) per 9 cm diameter dish, incubating for 1.5 h, followed by a chase for 1.5 h after the addition of unlabeled methionine to a final concentration of 300 gM. Tissue culture supernatants were collected, centrifuged to remove floating cells, and brought to 10 mM in N-acetylmaleimide. In the experiment shown in tracks 2-4, the tissue culture supernatants were passed three times over a gelatinSepharose column to remove fibronectin [ 115] . Immunoprecipitation was performed with commercial (Nordic, Tilburg, The Netherlands) rabbit anti-rat BIC (C3) serum. The immunoprecipitates were analyzed by SDS-polyacrylamide gel electrophoresis as described previously [37, 74] . 3) has not been identified of inherited C3 deficiency. The case concerns a patient whose serum levels of C3 were less than 1~ of normal [34] ; therefore, the hepatic pathway of production must have been severely affected by a mutation. However, peripheral blood monocytes taken from this patient and placed in primary tissue culture synthesized 25% of normal amounts of a C3 molecule, with apparently normal size and subunit composition. Therefore, the monocyte pathway of C3 biosynthesis may not have been as severely affected by the mutation as that of the liver. The appropriate control, in vitro biosynthesis of C3 by primary hepatocytes from this individual, could not be performed because the cells were not available. One direct attempt was made to determine whether hepatocytes and macrophage/monocytes synthesize different C3 molecules. However, after analyzing the spectrum ofisoelectric variants of h u m a n C3 from monocyte culture supernatants and from serum by immunofixation in isoelectric focusing gels, no difference was observed (Shiels and Hobart, personal communication). Thus, an interesting problem remains to determine why the h u m a n monocyte C3 product is hemolytically inactive, exactly how it differs from the liver product and what its physiologic role can be. Even if monocyte C3 lacks hemolytic activity, it should provide an adequate source of C3-derived peptide fragments, such as C3a. Therefore, one might reasonably speculate that an important role of the C3 polypeptide synthesized by peripheral cells might be to serve in the amplification of localized inflammatory responses in order to confine peripheral centers of inflammation. Such a role for fibroblast derived C3 has previously been proposed [-109 ].
The C3 gene provides a useful model for the study of the molecular mechanisms of tissue-specific gene expression for several reasons. First, there is a clear-cut difference in its expression in nonproducer and producer tissues; in the main producer tissue, liver hepatocytes, the gene is abundantly expressed. Second, apparently several types of producer tissues exist (major and minor producers) with possible molecular differences in the C3 protein that they produce. Finally, primary cells from several producer tissues continue to express C3 in culture (macrophages, monocytes, fibroblasts, synovial cells), and established hepatoma cell lines exist that secrete C3. Also, specific antisera, cloned cDNA, and genomic DNA sequences are available as tools to monitor gene expression. Recently, this range of tools has been further extended by the demonstration of C3 synthesis in two permanently established mouse macrophage tissue culture cell-lines [743 (Fig. 11, tracks 1 and 2 ). These cell lines, IC 21 and J774.2, other than producing C3 possess several other characteristic properties of differentiated macrophages [58, 68] . The ultimate goal of comparative studies with all these cells would be to explain at the molecular level the mechanisms that lead to differential expression of the C3 gene in various tissues.
B. Induction of C3 Synthesis in Acute Inflammation
Several of the complement components are acute phase reactants in the sense that their serum concentrations increase during severe acute and chronic inflammation and after major tissue damage and surgery [53, 66] . C2, C3, C4, C5b, C9, and factor B have been reported to increase in concentrations during infection and tissue injury [ 1, 12, 97] . Concentrations of some acute phase reactants such as C-reactive protein (CRP) and serum amyloid A-protein (SAA) begin to rise very rapidly (within a few hours after injury), whereas levels of C3 and ceruloplasmin rise more slowly (within 2-10 days). The acute phase proteins also differ markedly in the magnitude of their increase in concentration after stimulus. Concentrations of C3 increase about 50~o (from a normal value of 1.0-1.9 mg/ml to 2.2-2.6 mg/ml), whereas concentrations of CRP and SAA may increase several hundred-fold. C3 was reported to rise to 2.7 mg/ml within eight days in persons with bacterial meningitis, to 2.2 mg/ml in four to eight days in those with acute pyelonephritis and systemic lupus erythematosus, to 2.95 mg/ml in those with gonococcal arthritis, and to 2.2 mg/ml within one to two days after major surgery [54] . These values return to normal within a few days after disappearance of the inflammation. Because consumption of C3 usually increases as well, one may expect that the overall rate of synthesis may increase by more than 50~o. It is not known whether the heightened serum concentrations result from a faster rate of synthesis in only those cells that were synthesizing C3 before the onset of inflammation, or whether additional hepatocytes and possibly other types of producer cells (e. g., macrophages) are recruited for synthesis. Most of the acute phase plasma proteins are liver products, therefore, it might be expected that the majority of the newly synthesized C3 appearing in serum during the acute phase response is made by the liver. Many acute phase products of hepatocyte origin can be induced by Interleukin 1 [153 and a spectrum of other agents including glucocorticoids, synthetic steroid hormones, thyroxin, insulin, and breakdown fragments of fibrinogen [40] . However, no single major inflammatory inducer of C3 has been identified and well-characterized except for one report of C3 regulation by a glucocorticoid hormone [93] .
C. Involvement of Hormones in the Control of C3 Production
C3 concentrations are influenced by hormones. In humans, total amounts of complement activity and C3 increase significantly in maternal sera late in pregnancy [79] . Also, Strunk and colleagues [93] reported that the biosynthesis of C3 increased up to nine-fold after adding hydrocortisone succinate to cultured rat hepatoma cells, although the production of C3 and C5 in these cultures was not affected. This effect was observed in only one of four different C3 producing strains, the H4 hepatoma cell line. We have attempted to produce a similar effect with dexamethasone on two different established rat hepatoma cell lines, FaO [30] and HTC 1-100]. One of these, FaO, is a subline of the hepatoma from which the H4 line originated. Although both lines synthesized readily detectable amounts of C3 (Fig.  11 , tracks 3 and 4), no increase resulted. Instead, a two-fold decrease of C3 synthesis was observed, indicating that the published effect was specific for the particular cell line and possibly the particular derivative of the hormone that was used in the original study [-93] .
A variety of biosynthetic and secretory functions of macrophages can be regulated by dexamathasone [18, 103, 106, 107] . Because we had detected C3 synthesis in two established mouse macrophage-like cell lines [74] (Fig. 11, tracks 1 and 2), we determined whether dexamethasone would affect the synthesis and secretion of C3 in the J774.2 cell line. Synthesis and secretion both diminished approximately two-fold in a dose dependent manner with half maximal effect reached at a hormone concentration of 10-7M. This effect was partially reversible and both intracellular proC3 and extracellular native C3 were reduced to similar extents. Surprisingly, the C3 mRNA concentrations were reproducibly increased 1.5-fold under the same conditions. The mRNA concentrations were determined in quantitative Northern blot hybridizations by using radiolabeled, cloned cDNA probes for mouse C3 (Fig. 12A tracks 3 and 4) . The control [staining of the same tracks of the gel with ethidium bromide (Fig. 12A tracks 1 and 2) ] showed that equivalent amounts of total mRNA were contained in these tracks. The resulting data indicate that the hormone may affect the C3 mRNA and protein production in opposite ways. The hybridizations were calibrated with total mouse liver mRNA (Fig. 12A, tracks 5 to 7, Fig. 12B ). The results show that this RNA assay is sufficiently sensitive to detect a two-fold change in C3 mRNA concentration. With these new tools, a variety of experiments can now be performed to quantitate the tissuespecific and inflammation controlled expression of the C3 gene into primary transcripts and mature mRNA.
IV. Summary
To map the multiple interactive sites on the C3 polypeptide, it is advantageous to combine the approaches of protein chemistry, nucleic acid technology, and ~ug liver mRNA Fig. 12 , Titration of C3 mRNA in hormone-treated macrophage-like cells. For calibration purposes mouse liver RNA was extracted and mRNA was enriched by oligo-dT cellulose chromatography as described previously [75] . Total cellular RNA was extracted from cells (J774.2) in tissue culture with hot phenol and subsequently enriched for polyadenylated mRNA [88] . RNA samples were denatured in glyoxal [60] , electrophoresed in agarose gels, and transferred to nitrocellulose (Northern blot) as described previously [31] . Nicktranslated mouse C3 cDNA plasmid pMLC3-1 ( After a brief survey of reports describing inherited h u m a n C3 deficiencies, we discuss a Dutch family and their three members with total homozygous C3 deficiency who were the subjects of a recent publication. The restricted synthesis of C3 in major and minor producer tissues is discussed and it is proposed that the C3 gene provides a good model system for studying the molecular basis of tissue-specific gene expression. 
